Free Republic 2nd Qtr 2024 Fundraising Target: $81,000 Receipts & Pledges to-date: $13,140
16%  
Woo hoo!! And we're now over 16%!! Thank you all very much!! God bless.

Keyword: shinglesvaccine

Brevity: Headers | « Text »
  • Got a Shingles vaccine today (ages 50+)

    05/18/2022 9:31:21 AM PDT · by SpeedyInTexas · 86 replies
    18-MAY-2022 | self
    Got a Shingles vaccine today. 2 dose vaccine, 2-6 months apart. Recommended for ages 50+
  • Anyone here get a shingles vaccine and any complaints from it?

    07/31/2018 6:49:43 AM PDT · by fwdude · 110 replies
    self | 07/31/18 | fwdude
    Just wanted to get some feedback from experienced shingle sufferers and those who have opted for the vaccine. For the record, I got the first of a series of two shots a couple of weeks ago. More lingering soreness than with just about any other vaccine. Any reactions or did anyone suffer from shingles anyway?
  • Morally produced Shingles Vaccine moves closer to approval

    12/17/2017 3:49:50 PM PST · by Morgana · 34 replies
    cogforlife.org ^ | July 11, 2017 | CoG for Life Eric Sagonowsky |
    July 11, 2017 CoG for Life http://www.fiercepharma.com/vaccines/eager-for-marketing-approval-gsk-s-shingrix-passes-revaccination-test With GlaxoSmithKline eager for marketing approval, Shingrix passes revaccination test Awaiting a potential FDA approval, GlaxoSmithKline’s much-anticipated shingles vaccine Shingrix met its goal in a phase 3 study examining whether it can protect older adults who have previously received Merck’s Zostavax. If approved, CDC officials said they’re likely to recommend the GSK vaccine over Merck’s shot. In the revaccination study, investigators found that Glaxo’s shot induces a strong immune response in people 50 and older who received Zostavax a minimum of 5 years before their Shingrix vaccination. Since previous studies have shown Zostavax’s...
  • Vaccine Curbs Shingles Cases and Severity

    06/03/2005 12:22:39 AM PDT · by neverdem · 15 replies · 843+ views
    NY Times ^ | June 2, 2005 | ANDREW POLLACK
    An experimental vaccine can reduce both the incidence and the severity of shingles by more than half, doctors reported yesterday, in a development that could spare hundreds of thousands of elderly Americans from an extremely painful disease. The effectiveness of the vaccine was determined in an unusually large clinical trial involving more than 38,500 people over the age of 60, the group most prone to shingles, a skin and nerve infection. "I think the results are quite clinically significant," said Dr. Michael N. Oxman, the leader of the study, which is being published today in The New England Journal of...
  • SHINGLES VACCINE UNAVAILABLE???????????

    02/06/2007 4:27:47 AM PST · by finnsheep · 32 replies · 1,328+ views
    Feb 6, 2007 | finnsheep
    Is anyone else having trouble getting the new vaccination against shingles (Zostavax)? I started asking my doctor about it last fall when the CDC recommended it for most adults over age 60. The vaccination is expensive - - $150 to $200, but is good for several years. My pharmacy can get order one dose, but my doctor won't give me a prescription to bring to the pharmacy, where I guess I would pick up the vaccine - keep it frozen - - and then bring it to the doctor's office to get the injection. I am willing to pay for...